Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
Open accessThe DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Abstract
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary pathogenesis of diabetes is established, probably involving both genetic and environmental forces, hyperglycemia and very commonly hyperlipidemia ensue and thereafter exert additional damaging or toxic effects on the beta-cell. In addition to their contribution to the deterioration of beta-cell function after the onset of the disease, elevations of plasma fatty acid levels that often accompany insulin resistance may, as glucose levels begin to rise outside of the normal range, also play a pathogenic role in the early stages of the disease. Because hyperglycemia is a prerequisite for lipotoxicity to occur, the term glucolipotoxicity, rather than lipotoxicity, is more appropriate to describe deleterious effects of lipids on beta-cell function. In vitro and in vivo evidence supporting the concept of glucotoxicity is presented first, as well as a description of the underlying mechanisms with an emphasis on the role of oxidative stress. Second, we discuss the functional manifestations of glucolipotoxicity on insulin secretion, insulin gene expression, and beta-cell death, and the role of glucose in the mechanisms of glucolipotoxicity. Finally, we attempt to define the role of these phenomena in the natural history of beta-cell compensation, decompensation, and failure during the course of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The basis for this loss is multifactorial, and includes glucolipotoxicity32 and amyloid deposition that result in β-cell apoptosis through oxidative as well as endoplasmic reticulum stress31.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Research works printed but not linked: 1
- Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487–32490 [DOI] [PubMed] [Google Scholar]
Cited by
Items 301–400 of 999
Kang, Z. F., Deng, Y., Zhou, Y., Fan, R. R., Chan, J. C. N., Laybutt, D. R., Luzuriaga, J., & Xu, G. (2013) · Diabetologia · doi:10.1007/s00125-012-2776-x · Cited by 54
“This discrepancy in findings for GIP is possibly due to NEFA-induced global beta cell dysfunction via other pathways involving endoplasmic reticulum stress, oxidative stress and Ca homeostasis [29, 31].”
BackgroundKobiita, A., Godbersen, S., Araldi, E., Ghoshdastider, U., Schmid, M. W., Spinas, G. A., Moch, H., & Stoffel, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107846 · Cited by 58
Hellemans, K., Hannaert, J. C., Denys, B., Steffensen, K. R., Cindy, R., Martens, G. A., Veldhoven, P. P. V., Gustafsson, J.-Α., & PIPELEERS, D. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007266 · Cited by 57
The cytoprotective actions of long-chain mono-unsaturated fatty acids in pancreatic β-cells
Morgan, N. G., Dhayal, S., Diakogiannaki, E., & Welters, H. J. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360905 · Cited by 54
Nutritional Modulation of Insulin Resistance
Weickert, M. O. (2012) · Scientifica · doi:10.6064/2012/424780 · Cited by 53
Zhang, Y., Han, S., Liu, C., Zheng, Y., Li, H., Gao, F., Bian, Y., Liu, X., Liu, H., Hu, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36680-0 · Cited by 59
Teodoro-Morrison, T., Schuiki, I., Zhang, L., Belsham, D. D., & Volchuk, A. (2013) · Diabetologia · doi:10.1007/s00125-013-2855-7 · Cited by 60
Dreja, T., Jovanović, Z., Rasche, A., Kluge, R., Herwig, R., Tung, Y. C. L., Joost, H., Yeo, G. S. H., & Al‐Hasani, H. (2009) · Diabetologia · doi:10.1007/s00125-009-1576-4 · Cited by 60
“Several different mechanisms have been proposed to explain the negative effects of chronic hyperglycaemia [5].”
Nikzamir, A., Palangi, A., Kheirollaha, A., Tabar, H., Malakaskar, A., Shahbazian, H. B., & Fathi, M. (2014) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.13426 · Cited by 58
“This protein is the main factor required for glucose uptake from plasma and reduction of blood glucose (3, 4).”
BackgroundBlueberries’ Impact on Insulin Resistance and Glucose Intolerance
Stull, A. J. (2016) · Antioxidants · doi:10.3390/antiox5040044 · Cited by 61
The Arg–Phe‐amide peptide 26RFa/glutamine RF‐amide peptide and its receptor: IUPHAR Review 24
Leprince, J., Bagnol, D., Bureau, R., Fukusumi, S., Granata, R., Hinuma, S., Larhammar, D., Primeaux, S. D., Santos, J. S. O., Tsutsui, K., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13907 · Cited by 60
Stigmasterol prevents glucolipotoxicity induced defects in glucose-stimulated insulin secretion
Ward, M., Li, G., Barbosa-Lorenzi, V. C., & Hao, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-10209-0 · Cited by 59
The Hippo Signaling Pathway in Pancreatic β-Cells: Functions and Regulations
Ardestani, A. D., & Maedler, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00167 · Cited by 60
Early Insulin Treatment in Type 2 Diabetes
Meneghini, L. (2009) · Diabetes Care · doi:10.2337/dc09-s320 · Cited by 65
Mitochondria mediated cell death in diabetes
Szabadkai, G., & Duchen, M. R. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0363-5 · Cited by 60
“Stronger activation of stress responses can be achieved during combined glucolipotoxic conditions due to additive or potentiating effects of hyperglycaemia and elevated FFA concentrations [120], however no consensus has been reached on the mechanisms involved.”
BackgroundRole of different dietary saturated fatty acids for cardiometabolic risk
Iggman, D., & Risérus, U. (2011) · Clinical Lipidology · doi:10.2217/clp.11.7 · Cited by 57
The importance of synthetic drugs for type 2 diabetes drug discovery
Safavi, M., Foroumadi, A., & Abdollahi, M. R. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.837883 · Cited by 60
“In most obese and insulin-resistant individuals, b-cell compensation reduces due to hyperglycaemia and lipid toxicity [62,63].”
BackgroundZhong, Z., Chang, B., Li, M., Lian, F., Chen, L., Dong, L., Wang, J., Yu, B., Liu, W., Li, X., et al. (2011) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x11008646 · Cited by 52
Cantley, J., Burchfield, J. G., Pearson, G. L., Schmitz-Peiffer, C., Leitges, M., & Biden, T. J. (2009) · Diabetes · doi:10.2337/db09-0132 · Cited by 52
Shu, T., Zhu, Y., Wang, H., Lin, Y., Ma, Z., & Han, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018782 · Cited by 51
“roles in all forms of type 2 diabetes [2].”
BackgroundGranata, R., Settanni, F., Trovato, L., Gallo, D., Gesmundo, I., Nano, R., Gallo, M. P., Bergandi, L., Volante, M., Alloatti, G., et al. (2014) · Diabetes · doi:10.2337/db13-1522 · Cited by 55
Fukuda-Tsuru, S., Anabuki, J., Abe, Y., Yoshida, K., & Ishii, S. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.024 · Cited by 53
Improved characterization of the insulin secretory granule proteomes
Schvartz, D., Brunner, Y., Couté, Y., Foti, M., Wollheim, C. B., & Sanchez, J. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.04.023 · Cited by 51
Delghingaro-Augusto, V., Décary, S., Peyot, M.-L., Latour, M. G., Lamontagne, J., Paradis-Isler, N., Lacharité-Lemieux, M., Akakpo, H., Birot, O., Nolan, C. J., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00360.2011 · Cited by 49
Tedong, L., Madiraju, P., Martineau, L. C., Vallerand, D., Arnason, J. T., Désiré, D. D. P., Lavoie, L., Kamtchouing, P., & Haddad, P. S. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000045 · Cited by 49
Wehinger, S., Ortiz, R. J., Díaz, M. I., Aguirre, A., Valenzuela, M., Llanos, P., McMaster, C. R., Leyton, L., & Quest, A. F. G. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.021 · Cited by 50
Spégel, P., Ekholm, E., Tuomilehto, J., Groop, L., Mulder, H., & Filipsson, K. (2012) · Diabetes · doi:10.2337/db12-0827 · Cited by 50
Nayak, Y., Hillemane, V., Daroji, V. K., Jayashree, B. S., & Unnikrishnan, M. K. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/854267 · Cited by 48
Aharoni-Simon, M., Shumiatcher, R., Yeung, A., Shih, A. Z. L., Dolinsky, V. W., Doucette, C. A., & Luciani, D. S. (2016) · Endocrinology · doi:10.1210/en.2015-1964 · Cited by 57
Cunha, D. A., Cito, M., Grieco, F. A., Cosentino, C., Danilova, T., Ladrière, L., Lindahl, M., Domanskyi, A., Bugliani, M., Marchetti, P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.769877 · Cited by 55
Lu, J., Meng, Z., Cheng, B., Liu, M., Tao, S., & Guan, S. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7905 · Cited by 57
“Palmitic acid is a saturated high-grade fatty acid that is widely distributed in animal and vegetable oils in the form of glycerides, and is commonly used to establish lipotoxic in vitro and in vivo models (15).”
BackgroundAbebe, T., Mahadevan, J., Bogachus, L., Hahn, S., Black, M., Oseid, E., Urano, F., Cirulli, V., & Robertson, R. P. (2017) · JCI Insight · doi:10.1172/jci.insight.92854 · Cited by 47
“We have suggested that oxidative stress is a central mechanism for in vitro and in vivo glucose toxicity of β cells (28, 29).”
BackgroundSelf-citationRoles of Sphingolipid Metabolism in Pancreatic β Cell Dysfunction Induced by Lipotoxicity
Véret, J., Bellini, L., Giussani, P., Ng, C. K. ‐., Magnan, C., & Stunff, H. L. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3020646 · Cited by 54
Zhao, Y.-F., Wang, L., Lee, S., Sun, Q., Tuo, Y., Wang, Y., Pei, J., & Chen, C. (2009) · Endocrine · doi:10.1007/s12020-009-9275-y · Cited by 49
Glycemia Determines the Effect of Type 2 Diabetes Risk Genes on Insulin Secretion
Heni, M., Ketterer, C., Thamer, C., Herzberg-Schäfer, S. A., Guthoff, M., Stefan, N., Machicao, F., Staiger, H., Fritsche, A., & Häring, H.-U. (2010) · Diabetes · doi:10.2337/db10-0674 · Cited by 47
The Role of Peroxidation of Mitochondrial Membrane Phospholipids in Pancreatic β -Cell Failure
Ma, Z. A. (2011) · Current Diabetes Reviews · doi:10.2174/157339912798829232 · Cited by 53
“ROS, including superoxide anion (O2 •−), hydrogen peroxide (H2O2), and the hydroxyl radical (HO•), can be generated in non-mitochondrial sources including cytochrome P450 enzyme, NADPH oxidase, and 5-lipoxygenase [23, 24], but the mitochondria are the major source of ROS in pancreatic β-cells under metabolic stress [1…”
BackgroundGlucose regulation of β ‐cell stress in type 2 diabetes
Leibowitz, G., Bachar-Wikström, E., Shaked, M., Sinai, A., Ketzinel‐Gilad, M., Cerasi, E., & Kaiser, Ν. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01280.x · Cited by 51
“il β-cell function and survival unless hyperglycaemia has already been established [9,10].”
BackgroundInfluentialBarlow, J., Jensen, V. H., Jastroch, M., & Affourtit, C. (2016) · Biochemical Journal · doi:10.1042/bj20151080 · Cited by 45
Sheng, L., Cho, K. W., Zhou, Y., Shen, H., & Rui, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256677 · Cited by 45
Åkerfeldt, M. C., & Laybutt, D. R. (2011) · Diabetes · doi:10.2337/db11-0083 · Cited by 49
“The role of cellular stress and stress response mediators in the failure of b-cells in diabetes has been the subject of much recent attention (29,30).”
BackgroundManaging feline diabetes: current perspectives
Gottlieb, S., & Rand, J. S. (2018) · Veterinary Medicine Research and Reports · doi:10.2147/vmrr.s125619 · Cited by 66
Díaz-Gerevini, G. T., Daín, A., Pasqualini, M. E., López, C. B., Eynard, A. R., & Repossi, G. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-018-0938-7 · Cited by 52
Ahn, M., Yoder, S. M., Wang, Z., Oh, E., Ramalingam, L., Tunduguru, R., & Thurmond, D. C. (2016) · Diabetologia · doi:10.1007/s00125-016-4042-0 · Cited by 49
“results in beta cell decompensation and dysfunction and ultimately beta cell failure [42, 43]; our findings support the concept that PAK1 depletion represents a new type of genetic predisposition.”
Differential regulation of the ER stress response by long-chain fatty acids in the pancreatic β-cell
Diakogiannaki, E., & Morgan, N. G. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360959 · Cited by 44
Inflammation-Mediated Regulation of MicroRNA Expression in Transplanted Pancreatic Islets
Bravo-Egana, V., Rosero, S., Klein, D., Jiang, Z., Vargas, N., Tsinoremas, N., Doni, M., Podetta, M., Ricordi, C., Molano, R. D., et al. (2012) · Journal of Transplantation · doi:10.1155/2012/723614 · Cited by 43
Sidarala, V., Veluthakal, R., Syeda, K., Vlaar, C. P., Newsholme, P., & Kowluru, A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.04.001 · Cited by 43
“The current study was based on the hypothesis that HG induces Nox2 activation leading to subsequent activation of the downstream stress kinase signaling pathway culminating in the loss of GSIS in pancreatic β-cells.”
BackgroundInfluentialMondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic β-Cells
Richards, P., Rachdi, L., Oshima, M., Marchetti, P., Bugliani, M., Armanet, M., Postic, C., Guilmeau, S., & Scharfmann, R. (2017) · Diabetes · doi:10.2337/db17-0595 · Cited by 48
“Long-term hyperglycemic conditions have been shown to be detrimental to b-cell function, leading to decreased insulin transcription, synthesis, and secretion giving rise to the concept of glucolipotoxicity (4).”
BackgroundLi, J., Wu, N., Cheng, X. J., Chen, H., Yang, X., & Liu, C. (2019) · Islets · doi:10.1080/19382014.2019.1690944 · Cited by 48
Raptor determines β-cell identity and plasticity independent of hyperglycemia in mice
Yin, Q., Ni, Q., Wang, Y., Zhang, H., Li, W., Nie, A., Wang, S., Gu, Y., Wang, Q., & Ning, G. (2020) · Nature Communications · doi:10.1038/s41467-020-15935-0 · Cited by 42
Fatty acids and β-cell toxicity
Morgan, N. G. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328321e423 · Cited by 43
Barbarroja, N., López-Pedrera, C., Garrido‐Sánchez, L., Mayas, M. D., Oliva‐Olivera, W., Bernal-López, M. R., Bekay, R. E., & Tinahones, F. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048155 · Cited by 46
Syeda, K., Mohammed, A. M., Arora, D. K., & Kowluru, A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.08.023 · Cited by 41
“It is well established that chronic exposure of isolated b-cells to hyperglycemic conditions leads to metabolic dysfunction and demise [13,14].”
Tanabe, K., Liu, Y., Hasan, S. D., Martinez, S. C., CRAS-MÉNEUR, C. M. H., Welling, C. M., Bernal‐Mizrachi, E., Tanizawa, Y., Rhodes, C. J., Zmuda, E. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018146 · Cited by 48
“Under such conditions, the combination of hyperglycemia and FFA has been suggested to be particularly harmful for b-cells leading to so-called glucolipotoxicity [6,42,43].”
BackgroundFinucane, F. M., Sharp, S. J., Hatunic, M., Sleigh, A., Rolfe, E. D. L., Sayer, A. A., Cooper, C. C., Griffin, S. J., & Wareham, N. J. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-43 · Cited by 47
“The same pathophysiological processes that give rise to accumulation of ectopic fat within the liver are likely to account for impaired beta-cell function also [7].”
BackgroundExogenous Ketones Lower Blood Glucose Level in Rested and Exercised Rodent Models
Ari, C., Murdun, C., Koutnik, A. P., Goldhagen, C. R., Rogers, C. Q., Park, C. R., Bharwani, S., Diamond, D. M., Kindy, M. S., D’Agostino, D. P., et al. (2019) · Nutrients · doi:10.3390/nu11102330 · Cited by 47
Pros and cons of fatty acids in bone biology
Wauquier, F., Léotoing, L., Philippe, C., Spilmont, M., Coxam, V., & Wittrant, Y. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.03.001 · Cited by 46
Saisho, Y., Manesso, E., Butler, A. E., Galasso, R., Kavanagh, K., Flynn, M., Zhang, L., Clark, P., Gurlo, T., Toffolo, G. M., et al. (2011) · Diabetes · doi:10.2337/db09-1368 · Cited by 41
“The absence of increased b-cell apoptosis in the nonhuman primate administered STZ exposed to glucose values of ;300–400 mg/dL for up to 6 months is in contrast with the reported actions of high glucose concentrations to induce increased b-cell apoptosis (30).”
ResultMechanistic insights into pancreatic beta-cell mass regulation by glucose and free fatty acids
Oh, Y. S. (2015) · Anatomy & Cell Biology · doi:10.5115/acb.2015.48.1.16 · Cited by 49
Oh, Y. S., Lee, Y.-J., KANG, Y. Y., Han, J., Lim, O.-K., & Jun, H. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0311 · Cited by 43
“The loss of beta cell mass can be affected by environmental factors such as lipotoxicity and glucotoxicity (Poitout and Robertson 2008).”
BackgroundLocalization and regulation of pancreatic selenoprotein P
Steinbrenner, H., Hotze, A.-L., Speckmann, B., Pinto, A. V., Sies, H., Schott, M., Ehlers, M., Scherbaum, W. A., & Schinner, S. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0105 · Cited by 47
Circadian control of β ‐cell function and stress responses
Lee, J., Liu, R., de Jesus, D. S., Kim, B. S., Ma, K., Moulik, M., & Yechoor, V. K. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12524 · Cited by 44
“Indeed this has been hypothesized to be one of the important underlying causes of 𝛽-cell failure in many forms of T2D [71].”
BackgroundInfluentialGhrelin inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line
Wang, W., Zhang, D., Zhao, H., Chen, Y., Liu, Y., Cao, C.-P., Han, L., & Liu, G. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2009.12.017 · Cited by 42
Epigenetic modifiers of islet function and mass
Jesus, D. F. D., & Kulkarni, R. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.08.006 · Cited by 51
GPER/GPR30 Knockout Mice: Effects of GPER on Metabolism
Sharma, G., & Prossnitz, E. R. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3127-9_38 · Cited by 43
Loss of α2δ-1 Calcium Channel Subunit Function Increases the Susceptibility for Diabetes
Mastrolia, V., Flucher, S. M., Obermair, G. J., Drach, M., Hofer, H., Renström, E., Schwartz, A., Striessnig, J., Flucher, B. E., & Tuluc, P. (2017) · Diabetes · doi:10.2337/db16-0336 · Cited by 40
“to impaired insulin release and blood glucose regulation (41).”
BackgroundA direct look at the dysfunction and pathology of the β cells in human type 2 diabetes
Marchetti, P., Suleiman, M., Luca, C. D., Baronti, W., Bosi, E., Tesi, M., & Marselli, L. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.04.005 · Cited by 46
Activation of survival and apoptotic signaling pathways in lymphocytes exposed to palmitic acid
Takahashi, H., Cambiaghi, T. D., Luchessi, A. D., Hirabara, S. M., Vinolo, M. A. R., Newsholme, P., & Curi, R. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22740 · Cited by 40
Farsi, P. F., Djazayery, A., Eshraghian, M. R., Koohdani, F., Saboor-Yaraghi, A. A., Derakhshanian, H., Zarei, M., Javanbakht, M. H., & Djalali, M. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000002861 · Cited by 40
“Exposure to high NEFA concentrations causes dysfunction in glucose-stimulated insulin secretion (23).”
BackgroundGlucagon-like peptide–1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells
Wang, H.-W., Mizuta, M., Saitoh, Y., Noma, K., Ueno, H., & Nakazato, M. (2011) · Metabolism · doi:10.1016/j.metabol.2010.11.004 · Cited by 38
Kim, Y., Moon, J. S., Seo, Y. J., Park, S., Kim, J., Yoon, J. S., Lee, I., Lee, H. W., & Won, K. C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.020 · Cited by 42
Hyperinsulinism and Diabetes: Genetic Dissection of β Cell Metabolism-Excitation Coupling in Mice
Remedi, M. S., & Nichols, C. G. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.10.011 · Cited by 39
Gomes, J. M. G., Fabrini, S. P., & Alfenas, R. D. C. G. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000206 · Cited by 39
The role of dietary carbohydrates in organismal aging
Lee, D.-Y., Son, H. G., Jung, Y., & Lee, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2432-6 · Cited by 42
Pancreatic adipocytes mediate hypersecretion of insulin in diabetes-susceptible mice
Quiclet, C., Dittberner, N., Gässler, A., Stadion, M., Gerst, F., Helms, A., Baumeier, C., Schulz, T. J., & Schürmann, A. (2019) · Metabolism · doi:10.1016/j.metabol.2019.05.005 · Cited by 40
Liang, C., Hao, F., Yao, X., Qiu, Y., Liu, L., Wang, S., Yu, C.-L., Song, Z.-B., Bao, Y.-L., Yi, J., et al. (2019) · International Journal on Biological Sciences · doi:10.7150/ijbs.33817 · Cited by 37
“Glucotoxicity and lipotoxicity are diabetes-related phenomena that generate oxidative stress, which is implicated in the pathogenesis of β-cell dysfunction and apoptosis and is therefore associated with diabetes [35-36].”
BackgroundSaid, E., Mousa, S., Fawzi, M., Sabry, N. A., & Farid, S. F. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.06.013 · Cited by 47
Chueire, V. B., & Muscelli, E. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000313 · Cited by 50
“In turn, decreased incretin receptor signaling seems to contribute to gluco-lipotoxicity in combination with other pathways involving the endoplasmic reticulum and oxidative stress (68).”
BackgroundHigh Fat Programming of β-Cell Failure
Cerf, M. E. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_5 · Cited by 44
Clinical Approaches to Preserve β-Cell Function in Diabetes
WAJCHENBERG, B. L. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_23 · Cited by 41
Göhring, I., Sauter, N. S., Catchpole, G., Aßmann, A., Shu, L., Zien, K. S., Moehlig, M., Pfeiffer, A. F. H., Oberholzer, J., Willmitzer, L., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2249-7 · Cited by 39
“lactate dehydrogenase A, hexokinase, IL-1β, reactive oxygen species [ROS]) [3–6].”
BackgroundLipotoxicity is glucose-dependent in INS-1E cells but not in human islets and MIN6 cells
Sargsyan, E., & Bergsten, P. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-115 · Cited by 45
Diminished stress resistance and defective adaptive homeostasis in age-related diseases
Lomeli, N., Bota, D. A., & Davies, K. J. A. (2017) · Clinical Science · doi:10.1042/cs20160982 · Cited by 41
Untimely oxidative stress in β-cells leads to diabetes – Role of circadian clock in β-cell function
Lee, J. M., Ma, K., Moulik, M., & Yechoor, V. K. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.02.022 · Cited by 41
Regeenes, R., Silva, P. N., Chang, H. H., Arany, E. J., Иванович, Ш. А., Audet, J., Kilkenny, D. M., & Rocheleau, J. V. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003036 · Cited by 43
Omori, K., Nakamura, A., Miyoshi, H., Takahashi, K., Kitao, N., Nomoto, H., Kameda, H., Cho, K. Y., Takagi, R., Hatanaka, K. C., et al. (2019) · Metabolism · doi:10.1016/j.metabol.2019.06.006 · Cited by 42
Lorza‐Gil, E., Salerno, A. G., Wanschel, A. C. B. A., Vettorazzi, J. F., Ferreira, M. S., Rentz, T., Catharino, R. R., & Oliveira, H. C. F. (2016) · Toxicology · doi:10.1016/j.tox.2015.12.007 · Cited by 41
Glucose metabolism: key endogenous regulator of β‐cell replication and survival
Dadon, D., Tornovsky-Babaey, S., Furth‐Lavi, J., Ben-Zvi, D. S., Ziv, O., Schyr, R. B., Stolovich-Rain, M., Hija, A., Porat, S., Granot, Z., et al. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01646.x · Cited by 41
Systemic Effects of White Adipose Tissue Dysregulation and Obesity‐Related Inflammation
Guri, A. J., & Bassaganya-Riera, J. (2011) · Obesity · doi:10.1038/oby.2010.230 · Cited by 43
C‐peptide antioxidant adaptive pathways in β cells and diabetes
Luppi, P., & Drain, P. F. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12522 · Cited by 47
Degradable Nanoparticles Restore Lysosomal pH and Autophagic Flux in Lipotoxic Pancreatic Beta Cells
Zeng, J., Shirihai, O. S., & Grinstaff, M. W. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801511 · Cited by 40
Zhang, X., Zhang, Y., Zhou, M., Xie, Y., Dong, X., Bai, F., & Zhang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.792977 · Cited by 38
Metabolomics applied to the pancreatic islet
Gooding, J. R., Jensen, M. V., & Newgard, C. B. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.06.013 · Cited by 37
Role of palmitate-induced sphingoid base-1-phosphate biosynthesis in INS-1 β-cell survival
Véret, J., Coant, N., Gorshkova, I. A., Giussani, P., Fradet, M., Riccitelli, E., Skobeleva, A., Goya, J., Kassis, N., Natarajan, V., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.10.003 · Cited by 42
Green, C. D., Jump, D. Β., & Olson, L. K. (2009) · Endocrinology · doi:10.1210/en.2008-1039 · Cited by 37
The Effect of ACACB cis-Variants on Gene Expression and Metabolic Traits
Ma, L., Mondal, A. K., Murea, M., Sharma, N. K., Tönjes, A., Langberg, K. A., Das, S. K., Franks, P. W., Kovacs, P. L., Antinozzi, P. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023860 · Cited by 39
“The resulting organ dysfunction, known as ‘‘lipotoxicity’’, results in impaired insulin action and glucose homeostasis, and ultimately type 2 diabetes; however, the cellular mechanisms and intermediates are not fully understood [7–11].”
Han, D., Moon, S., Kim, H., Choi, S., Lee, S., Park, K. S., Jun, H., KANG, Y. Y., & Kim, Y. (2010) · Journal of Proteome Research · doi:10.1021/pr100759a · Cited by 43
Arora, D. K., Machhadieh, B., Matti, A., Wadzinski, B. E., Ramanadham, S., & Kowluru, A. (2013) · Endocrinology · doi:10.1210/en.2013-1773 · Cited by 39
Shih, P., Hwang, S.-L., Yeh, C., & Yen, G. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf300005v · Cited by 40
Innovative Thoughts on Treating Diabetes from the Perspective of Traditional Chinese Medicine
Pang, B., Zhou, Q., Zhao, T., He, L., Guo, J., Chen, H., Zhao, L., & Tong, X. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/905432 · Cited by 36
Szkudlinska, M. A., von Frankenberg, A. D., & Utzschneider, K. M. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.02.003 · Cited by 41
“Hyperglycemia can exacerbate β-cell dysfunction, with oxidative stress proposed as a major mediator of this “glucotoxic” effect (Boden, Ruiz, Kim, & Chen, 1996; Poitout & Robertson, 2008).”
Background
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- Pacific Northwest Research Institute (US)
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-05
- Volume
- 29
- Issue
- 3
- Pages
- 351-366
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2528858
- OpenAlex
- W2082515526
- Cited by
- 1,092
- References
- 198
- Citations by year
- 2026: 47 · 2025: 55 · 2024: 37 · 2023: 42 · 2022: 38 · 2021: 57 · 2020: 61 · 2019: 50 · 2018: 44 · 2017: 61 · 2016: 79 · 2015: 64 · 2014: 59 · 2013: 81 · 2012: 84
- FWCI
- 81.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (77686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096, R01DK038325, R01DK058096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucolipotoxicity, glucotoxicity, lipotoxicity, type 2 diabetes, beta-cell dysfunction, hyperglycemia, hyperlipidemia, oxidative stress, insulin secretion, insulin gene expression, beta-cell death, insulin resistance, beta-cell compensation, beta-cell failure
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Glucose, Humans, Lipid Metabolism, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.